Immunologic changes point to potential for clinical investigation of combination immunotherapy for deadly kidney cancer – Science Daily
|
Immunologic changes point to potential for clinical investigation of combination immunotherapy for deadly kidney cancer
Science Daily Immunologic changes observed in an early study of patients with metastatic renal cell carcinoma (MRCC) raised the possibility for a larger clinical study of combination immunotherapy, according to findings reported by researchers at The University of … |
